Versant Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Other funds holding RYTM
BBA
Versant Capital Management's RYTM Position: Q3 2026 in Review
Versant Capital Management increased its Rhythm Pharmaceuticals (RYTM) stake by 83% in Q3 2026, buying an estimated $3.2K and bringing the position to 66 shares worth $6.28K. The position accounts for ﹤0.01% of the portfolio, ranked #2407.
Versant Capital Management first reported a position in RYTM in Q1 2025 and has held it in 7 quarters since. 334 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.
- Versant Capital Management held 66 shares of Rhythm Pharmaceuticals worth $6.28K as of Q3 2026.
- Versant Capital Management bought 30 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $3.2K.
- Rhythm Pharmaceuticals made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2407 holding.
- Versant Capital Management first reported a position in Rhythm Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
- 334 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.